-
Delcath Systems, Inc. (NASDAQ: DCTH) is a
publicly traded specialty pharmaceutical and
medical device company, that
develops percutaneous perfusion technologies...
-
article incorporates text from this source,
which is in the
public domain. "
Delcath Systems, Inc.
Announces FDA
Approval of
Hepzato Kit for the
Treatment of...
-
served as the
chairman of the
board of a
medical devices company called Delcath from 2007 to 2011.
While Koplewicz worked at NYU Langone, he also served...
-
specialty drugs,
melphalan (trade name Alkeran), busulfan, capecitabine).
Delcath Systems, Inc. (NASDAQ: DCTH) a
specialty pharmaceutical and
medical device...
- a
radiology suite under local or
general anesthesia.[citation needed]
Delcath Systems Morita,
Shane Y.; Balch,
Charles M.; Klimberg, V. Suzanne; Pawlik...
-
prostate cancer. 2012 –
Pioneering liver chemoperfusion study reported by
Delcath for
disseminated liver metastases.
While the
surgical resection of tumours...
